In this issue of the Journal of Stroke and Cerebrovascular Diseases, and Dr. Yaghi and colleagues retrospectively analyze data from the National Inpatient
Sample to highlight disparities in inpatient placement of insertable cardiac monitors
after ischemic stroke.
1
Inpatient placement of insertable cardiac monitors affords providers and patients
the ability to monitor the greatest length of time after ischemic stroke for paroxysmal
atrial fibrillation without missing critical periods if placement is deferred to the
outpatient setting. Therefore, inpatient placement of insertable cardiac monitors
has gained momentum in the etiologic evaluation of patients with cryptogenic strokes
as recent trials of anticoagulation were not found to be superior to antiplatelet
monotherapy in reducing recurrent stroke.
2
,
3
Thus, documenting atrial fibrillation remains the prerequisite before initiating
anticoagulation in patients with cryptogenic stroke.To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of Stroke and Cerebrovascular DiseasesAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Differences in inpatient insertable cardiac monitor placement after ischemic stroke.J Stroke Cerebrovasc Dis. 2021;
- Dabigatran for prevention of stroke after embolic stroke of undetermined source.N Engl J Med. 2019; 380: 1906-1917https://doi.org/10.1056/NEJMoa1813959
- Rivaroxaban for stroke prevention after embolic stroke of undetermined source.N Engl J Med. 2018; 378: 2191-2201https://doi.org/10.1056/NEJMoa18 02686
- Health equity.Stroke. 2021; 52: 2972-2973https://doi.org/10.1161/STROKEAHA.121.033939
- Racial differences by ischemic stroke subtype: a comprehensive diagnostic approach.Stroke Res Treat. 2012; 2012735097https://doi.org/10.1155/2012/735097
- The atrial cardiopathy and antithrombotic drugs in prevention after cryptogenic stroke randomized trial: rationale and methods.Int J Stroke. 2019; 14: 207-214https://doi.org/10.1177/1747493018799981
Article info
Publication history
Published online: October 12, 2021
Identification
DOI: https://doi.org/10.1016/j.jstrokecerebrovasdis.2021.106153
Copyright
© 2021 Elsevier Inc. All rights reserved.
ScienceDirect
Access this article on ScienceDirectLinked Article
- Differences in Inpatient Insertable Cardiac Monitor Placement after Ischemic StrokeJournal of Stroke and Cerebrovascular DiseasesVol. 31Issue 1
- PreviewCryptogenic stroke accounts for 30% of ischemic stroke and in such patients, cardiac monitoring leads to increased detection of AF, increased utilization of anticoagulation, and decreased risk of recurrent stroke. We aim to identify differences in inpatient utilization of implantable cardiac monitors (ICMs) in patients with ischemic stroke.
- Full-Text
- Preview
